Patrick SoonShiong - NantKwest Chairman of the Board, CEO
Chairman
Dr. Patrick SoonShiong, M.D., serves as a Chairman of the Board, Chief Executive Officer of the Company. Dr. SoonShiong was appointed Chairman of our board of directors and Chief Executive Officer in March 2015. Dr. SoonShiong previously served as our CoChairman of our board of directors from December 2014 to March 2015 and as our Chief Medical Officer from January 2015 to March 2015. In 2011, he founded NantWorks, an ecosystem of companies to create a transformative global health information and next generation pharmaceutical development network, for the secure sharing of genetic and medical information. Dr. SoonShiong, a physician, surgeon and scientist, has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers, and has over 230 issued patents on groundbreaking advancements spanning a myriad of fields. Dr. SoonShiong performed the worlds first encapsulated human islet transplant, the first engineered islet cell transplant, and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nations first FDA approved protein nanoparticle albuminbound delivery technology for the treatment of cancer. Abraxane was approved by the FDA for metastatic breast cancer in 2005, lung cancer in 2012, and pancreatic cancer in 2013. Abraxane is now approved in many countries across the globe. From 1997 to 2010, Dr. SoonShiong served as founder, Chairman, and CEO of two global pharmaceutical companies, American Pharmaceutical Partners and Abraxis BioScience . Dr. SoonShiong serves as Chairman of the Chan SoonShiong Family Foundation and Chairman and CEO of the Chan SoonShiong Institute of Molecular Medicine, a nonprofit medical research organization. since 2015.
| Age | 65 |
| Tenure | 9 years |
| Professional Marks | Ph.D |
| Phone | 858 633-0300 |
| Web | www.nantkwest.com |
Patrick SoonShiong Latest Insider Activity
Tracking and analyzing the buying and selling activities of Patrick SoonShiong against NantKwest stock is an integral part of due diligence when investing in NantKwest. Patrick SoonShiong insider activity provides valuable insight into whether NantKwest is net buyers or sellers over its current business cycle. Note, NantKwest insiders must abide by specific rules, including filing SEC forms every time they buy or sell NantKwest'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Patrick SoonShiong over six months ago Nanthealth LLC exotic insider transaction detected |
NantKwest Management Efficiency
The company has Return on Asset (ROA) of (38.83) % which means that for every 100 dollars spent on asset, it generated a loss of $38.83. This is way below average. Likewise, it shows a return on total equity (ROE) of (77.61) %, which implies that it produced no returns to current stockholders. NantKwest's management efficiency ratios could be used to measure how well NantKwest manages its routine affairs as well as how well it operates its assets and liabilities.The company reports 15.31 M of total liabilities with total debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from financial leverage. NantKwest has a current ratio of 3.0, indicating that it is in good position to pay out its debt commitments in time. Debt can assist NantKwest until it has trouble settling it off, either with new capital or with free cash flow. So, NantKwest's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NantKwest sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NantKwest to invest in growth at high rates of return. When we think about NantKwest's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 9 records | CHAIRMAN Age | ||
| Bernard Aldrich | Apogee Enterprises | 67 | |
| Elaine Rosen | Assurant | 68 | |
| James Sutcliffe | Sun Life Financial | 58 | |
| Curt Culver | MGIC Investment Corp | 69 | |
| Robert Lippincott | Kinsale Capital Group | 73 | |
| Cynthia Egan | The Hanover Insurance | 66 | |
| William Anderson | Sun Life Financial | 70 | |
| Michael Angelini | The Hanover Insurance | 73 | |
| Alain Bedard | TFI International | 67 | |
Management Performance
| Return On Equity | -77.61 | |||
| Return On Asset | -38.83 |
NantKwest Leadership Team
Elected by the shareholders, the NantKwest's board of directors comprises two types of representatives: NantKwest inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NantKwest. The board's role is to monitor NantKwest's management team and ensure that shareholders' interests are well served. NantKwest's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NantKwest's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl Cohen, Director | ||
| Richard Kusserow, Independent Director | ||
| Angela Wilson, CFO | ||
| Sonja Nelson, Chief Accounting Officer | ||
| Barry Simon, President CEO, Board Member | ||
| Michael Blaszyk, Independent Director | ||
| Frederick Driscoll, Independent Director | ||
| John Thomas, Independent Director | ||
| Robert Rosen, Director | ||
| Richard Tajak, Interim CFO | ||
| Patrick SoonShiong, Chairman of the Board, CEO | ||
| Henry Ji, Director | ||
| John Potts, Independent Director | ||
| Steven Gorlin, Vice Chairman of the Board |
NantKwest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NantKwest a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -77.61 | |||
| Return On Asset | -38.83 | |||
| Current Valuation | 2.76 B | |||
| Shares Outstanding | 108.88 M | |||
| Shares Owned By Insiders | 67.98 % | |||
| Shares Owned By Institutions | 9.78 % | |||
| Number Of Shares Shorted | 5.43 M | |||
| Price To Earning | (3.44) X | |||
| Price To Book | 19.58 X | |||
| Revenue | 111 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NantKwest in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NantKwest's short interest history, or implied volatility extrapolated from NantKwest options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in NantKwest Stock
If you are still planning to invest in NantKwest check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NantKwest's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |